Chemed Price to Sales Ratio 2010-2024 | CHE

Historical PS ratio values for Chemed (CHE) over the last 10 years. The current P/S ratio for Chemed as of November 22, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-11-21 563.28 3.61
2024-09-30 600.43 $156.00 3.85
2024-06-30 541.62 $153.17 3.54
2024-03-31 640.79 $150.49 4.26
2023-12-31 583.32 $149.15 3.91
2023-09-30 518.08 $146.81 3.53
2023-06-30 539.56 $144.67 3.73
2023-03-31 535.28 $143.44 3.73
2022-12-31 507.72 $141.29 3.59
2022-09-30 433.91 $139.02 3.12
2022-06-30 466.18 $138.03 3.38
2022-03-31 502.72 $135.93 3.70
2021-12-31 524.65 $133.52 3.93
2021-09-30 460.93 $131.85 3.50
2021-06-30 469.86 $128.52 3.66
2020-12-31 526.63 $126.69 4.16
2020-09-30 474.63 $125.77 3.77
2020-06-30 445.40 $125.84 3.54
2020-03-31 427.46 $124.20 3.44
2019-12-31 433.11 $121.76 3.56
2021-03-31 455.01 $118.12 3.85
2019-09-30 411.40 $113.01 3.64
2019-06-30 355.25 $110.46 3.22
2019-03-31 314.82 $107.95 2.92
2018-12-31 278.38 $106.00 2.63
2018-09-30 313.76 $104.36 3.01
2018-06-30 315.65 $102.91 3.07
2018-03-31 267.41 $102.55 2.61
2017-12-31 237.91 $100.70 2.36
2017-09-30 197.56 $99.15 1.99
2017-06-30 199.70 $97.82 2.04
2017-03-31 178.14 $95.09 1.87
2016-12-31 156.19 $93.67 1.67
2016-09-30 137.10 $92.52 1.48
2016-06-30 132.23 $90.98 1.45
2016-03-31 131.16 $89.71 1.46
2015-12-31 144.79 $88.54 1.64
2015-09-30 128.80 $86.93 1.48
2015-06-30 126.30 $85.09 1.48
2015-03-31 114.83 $83.31 1.38
2014-12-31 101.43 $80.50 1.26
2014-09-30 98.57 $77.64 1.27
2014-06-30 89.58 $76.14 1.18
2013-12-31 72.90 $75.29 0.97
2013-09-30 67.85 $75.59 0.90
2013-06-30 68.54 $76.76 0.89
2013-03-31 75.49 $76.19 0.99
2012-12-31 64.59 $75.18 0.86
2014-03-31 85.31 $74.36 1.15
2012-09-30 65.06 $71.51 0.91
2012-06-30 56.59 $69.46 0.81
2012-03-31 58.52 $66.58 0.88
2011-12-31 47.69 $63.69 0.75
2011-09-30 51.04 $61.57 0.83
2011-06-30 60.67 $59.29 1.02
2011-03-31 61.55 $57.53 1.07
2010-12-31 58.56 $55.60 1.05
2010-09-30 52.41 $54.33 0.96
2010-06-30 50.13 $53.45 0.94
2010-03-31 49.79 $52.82 0.94
2009-12-31 43.82 $52.43 0.84
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.593B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00